MENU
+Compare
MRUS
Stock ticker: NASDAQ
AS OF
Mar 11, 04:59 PM (EDT)
Price
$47.65
Change
+$0.90 (+1.93%)
Capitalization
3.23B

MRUS Merus NV Forecast, Technical & Fundamental Analysis

Merus NV is a clinical-stage immuno-oncology company... Show more

Industry: #Biotechnology
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MRUS with price predictions
Mar 10, 2025

MRUS in upward trend: price rose above 50-day moving average on February 18, 2025

MRUS moved above its 50-day moving average on February 18, 2025 date and that indicates a change from a downward trend to an upward trend. In of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on March 10, 2025. You may want to consider a long position or call options on MRUS as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 10-day moving average for MRUS crossed bullishly above the 50-day moving average on February 20, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MRUS advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 223 cases where MRUS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MRUS moved out of overbought territory on February 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where MRUS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRUS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MRUS broke above its upper Bollinger Band on February 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.985) is normal, around the industry mean (11.728). P/E Ratio (0.000) is within average values for comparable stocks, (64.307). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.787). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (83.333) is also within normal values, averaging (234.781).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MRUS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MRUS is expected to report earnings to rise 120.58% to -99 cents per share on May 13

Merus NV MRUS Stock Earnings Reports
Q1'25
Est.
$-0.99
Q4'24
Beat
by $0.51
Q3'24
Missed
by $0.60
Q2'24
Missed
by $0.05
Q1'24
Beat
by $0.22
The last earnings report on February 27 showed earnings per share of -44 cents, beating the estimate of -95 cents. With 370.12K shares outstanding, the current market capitalization sits at 3.23B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for cancer treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Uppsalalaan 17
Phone
+31 302538800
Employees
229
Web
https://www.merus.nl
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X78532.000000-2069.039000
-2.57%
Bitcoin cryptocurrency
SPY560.58-15.34
-2.66%
SPDR® S&P 500® ETF Trust
AAPL227.48-11.59
-4.85%
Apple
GME22.42-1.58
-6.58%
GameStop Corp
TSLA222.15-40.52
-15.43%
Tesla

MRUS and Stocks

Correlation & Price change

A.I.dvisor tells us that MRUS and CGON have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRUS and CGON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRUS
1D Price
Change %
MRUS100%
+1.48%
CGON - MRUS
32%
Poorly correlated
-1.98%
ACLX - MRUS
30%
Poorly correlated
+1.95%
IMTX - MRUS
30%
Poorly correlated
-3.43%
CGEM - MRUS
29%
Poorly correlated
-6.43%
RCKT - MRUS
29%
Poorly correlated
-2.05%
More

Groups containing MRUS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRUS
1D Price
Change %
MRUS100%
+1.48%
therapeutics
theme (52 stocks)
37%
Loosely correlated
-0.60%
cancer
theme (81 stocks)
35%
Loosely correlated
+0.13%
treatment
theme (53 stocks)
32%
Poorly correlated
-0.49%
drugs
theme (249 stocks)
31%
Poorly correlated
+0.54%
europe
theme (179 stocks)
27%
Poorly correlated
-0.31%
More